Natco Pharma Ltd. (NATCOPHARM): Natco Pharma Share Price near 52-week low as stock trades at Rs 803.5

Natco Pharma Share Price is trading at Rs 803.5 on 05 October 2026 at 11:22 AM IST, down 2.22% from the previous session and very close to its 52-week low. The company’s market capitalisation stands at Rs 16,120.1 crore, placing Natco Pharma Ltd. (NATCOPHARM) among mid-sized pharmaceutical names in the Indian market. Natco Pharma Share Price Today is drawing attention because the move confirms weakness in price action, even though the supplied data does not establish a company-specific catalyst. For Natco Pharma Stock News, the key point is that the stock is trading near a yearly low while fundamentals remain relevant for valuation-led investors tracking Natco Pharma Share Price, Natco Pharma Share Price Today and Natco Pharma Stock News.

The intraday path shows that Natco Pharma Share Price opened at Rs 822.9, touched a high of Rs 827.65 and a low of Rs 803.5, which is also the current price. That makes the move a clear bearish intraday setup in Stock Market Today terms, with selling pressure visible from the open. Because the stock is near a 52-week trough, Natco Pharma Share Price Today is being watched as a price-action story first and a fundamental story second. Univest coverage focuses on whether the weakness reflects broader Market News or stock-specific issues, but the verified data only confirms the price event, not a fresh trigger.

Natco Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 803.5
Previous Close	Rs 821.75
Today's Move	Rs -18.25 (-2.22%)
Open	Rs 822.9
High	Rs 827.65
Low	Rs 803.5
Market Capitalisation	Rs 16,120.1 crore

Natco Pharma Ltd. (NATCOPHARM) traded at Rs 803.5 versus the previous close of Rs 821.75, a fall of 2.22%. The stock opened at Rs 822.9, reached a high of Rs 827.65, touched a low of Rs 803.5.

Natco Pharma Share Price Today shows a Rs 18.25 decline from the previous close of Rs 821.75, which translates into a 2.22% fall. The stock opened slightly above the prior close, but the day high stayed limited at Rs 827.65 before the price slipped to Rs 803.5. That pattern suggests weak buying follow-through and makes Natco Pharma Share Price Today a stock to watch in the context of Top Losers Today and Stocks in News. In Share Market Today language, the move also places Natco Pharma among Stocks at 52 Week Low territory, even though the price has not set any all-time low. Natco Pharma Share Price remains well below the recent short-term average reference levels and the market is treating the move as a support test rather than a breakout setup.

For investors tracking Natco Pharma Share Price Update, the important message is simple: the stock is trading close to its 52-week low, and the latest Price Action shows limited intraday recovery after the early high. Univest notes that such behaviour often keeps Share Price Live searches active because traders want to see whether support holds or weakens further. Natco Pharma Share Price Today therefore stays important for short-term market reading, while Natco Pharma Stock News remains centred on verified price behaviour rather than an unconfirmed trigger.

Natco Pharma Ltd. (NATCOPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 16,120.1 crore
P/E Ratio	14.09x
P/B Ratio	1.72x
ROE	16.3%
ROCE	17.16%
EPS	Rs 58.33
Book Value Per Share	Rs 476.47
Dividend Yield	0.6%

Natco Pharma Ltd. (NATCOPHARM) fundamental metrics show P/E 14.09x, P/B 1.72x, ROE 16.3%, ROCE 17.16%. These figures provide context only and are not a buy or sell signal.

Natco Pharma Ltd. has a market capitalisation of Rs 16120.1 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 14.09x, P/B at 1.72x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.3% and ROCE of 17.16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 58.33, book value per share of Rs 476.47, dividend yield of 0.6%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 27.53x, median ROE of 11.43%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	14.09x
Benchmark Median P/E	27.53x
Benchmark Average P/E	40.45x
Benchmark P/E Range	0x to 685.2x
Company P/B Ratio	1.72x
Benchmark Median P/B	2.81x
Company ROE	16.3%
Benchmark Median ROE	11.43%
Company ROCE	17.16%
Benchmark Median ROCE	13.1%
Company Market Capitalisation	Rs 16,120.1 crore
Benchmark Median Market Cap	Rs 695.84 crore

Natco Pharma Ltd. (NATCOPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Natco Pharma Ltd. (NATCOPHARM) has a P/E ratio of 14.09x, which is below the benchmark median of 27.53x, a difference of -48.82%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Natco Pharma Ltd. (NATCOPHARM) has a ROE of 16.3%, which is above the benchmark median of 11.43%, a difference of +42.61%. Natco Pharma Ltd. (NATCOPHARM) has a ROCE of 17.16%, which is above the benchmark median of 13.1%, a difference of +30.99%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Alembic Pharmaceuticals Ltd.	APLLTD	16,019.89	23.1	2.74	12.35	11.74
Jubilant Pharmova Ltd.	JUBLPHARMA	15,938.47	45.27	2.24	5.97	8.69
Eris Lifesciences Ltd.	ERIS	16,507.81	25.64	4.09	19.23	14.47
Glenmark Life Sciences Ltd.	ALIVUS	16,849.15	27.94	4.83	18.41	24.61
Astrazeneca Pharma India Ltd.	ASTRAZEN	15,076.13	88.88	16.67	23.02	31.24

Natco Pharma Ltd. (NATCOPHARM) has a P/E ratio of 14.09x compared with the displayed peer median of 27.94x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.3% compares with a peer median of 18.41% across the companies shown in the table. ROCE stood at 17.16% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Natco Pharma Ltd. (NATCOPHARM) has a market capitalisation of Rs 16,120.1 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Natco Pharma

• Natco Pharma Share Price is trading near its 52-week low, so price action is the first thing market participants are checking.
• Natco Pharma Share Price Today is below the 50 DMA of Rs 851.12 and the 200 DMA of Rs 938.27, which keeps momentum weak.
• Natco Pharma Fundamental Analysis shows P/E and P/B below sector medians, while ROE and ROCE stay above benchmark levels.
• Natco Pharma Share News is also relevant because the company’s market cap is Rs 16,120.1 crore, keeping it in a tracked institutional bracket.
• Natco Pharma Stock News remains active because the valuation gap versus peers and the sector benchmark creates a clear comparison point.

About Natco Pharma

Natco Pharma Ltd. operates in Pharmaceuticals & Drugs within the Healthcare sector. The company’s share price behaviour often attracts Natco Pharma Share Price searches because investors track it both as a listed pharma name and as a valuation case. Based on the supplied financial data, the business has generated revenue and net profit across multiple recent quarters, which helps frame Natco Pharma Stock Performance beyond daily price movement. The company is large enough to matter in the mid-cap pharma space, with a market capitalisation of Rs 16,120.1 crore, but its valuation remains moderate relative to the broader industry. For Natco Pharma Share Price Today, that combination of scale, earnings and sector placement is why the stock keeps appearing in Natco Pharma Company News, Natco Pharma Latest News and Natco Pharma Stock Analysis discussions on Univest.

Track Natco Pharma Share Price on Univest

Use Natco Pharma Ltd. (NATCOPHARM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Track Natco Pharma Share Price on Univest for live share price updates, key technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Natco Pharma Share Price Today alongside Natco Pharma Stock News, sector context and peer comparisons in one place. That makes it easier to review Natco Pharma Share Price Live, Natco Pharma Share Price Update and Natco Pharma Technical Analysis-style data without switching across multiple screens.

Frequently Asked Questions

Why is Natco Pharma Share Price falling today?

Ans. Natco Pharma Share Price is down 2.22% to Rs 803.5 from Rs 821.75. The supplied data confirms the price event near a 52-week low, but it does not establish a company-specific catalyst.

What is Natco Pharma Share Price today?

Ans. Natco Pharma Share Price is Rs 803.5 at 11:22 AM IST on 05 October 2026. It traded between Rs 803.5 and Rs 827.65 during the day, keeping it close to a yearly low.

How close is Natco Pharma Share Price to its 52-week low?

Ans. Natco Pharma Share Price is trading near its 52-week low, which is why it appears in a near-52-week-low screen. The move places the stock in a weak intraday price zone.

Is Natco Pharma Share Price expensive or cheap?

Ans. Natco Pharma Share Price looks moderate on valuation. Its P/E of 14.09 and P/B of 1.72 are below the same-industry medians, while ROE and ROCE are above benchmark levels. The stock moved -2.22% during the session.

How does Natco Pharma compare with peers?

Ans. Natco Pharma Share Price trades at a lower P/E and P/B than several peers such as Alembic Pharmaceuticals, Eris Lifesciences and Glenmark Life Sciences. That supports a lower-multiple peer comparison.

What is Natco Pharma market cap?

Ans. Natco Pharma has a market capitalisation of Rs 16,120.1 crore. That keeps Natco Pharma Share Price within a sizeable listed pharma bracket rather than a small-cap segment. The company operates in the Healthcare sector.

What are Natco Pharma’s key profitability metrics?

Ans. Natco Pharma reports ROE of 16.3%, ROCE of 17.16%, EPS of Rs 58.33 and book value per share of Rs 476.47. Those figures help explain its fundamental profile. ROE stands at 16.3%.